Effects of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome - Feig, PU; Shah, S; Hermanowski-Vosatka, A (Diabetes Obes Metab, 2011)
et al.